Previous deleterious variants in patients with CPVT have been identified in the sixth exon of TECRL and the splice donor site of intron 3 resulting in an internal deletion (Devalla et al, 2016). This evidence concerns the gene TECRL and catecholaminergic polymorphic ventricular tachycardia.